302711000001100: Xanthomax 300 tablets (Ashbourne Pharmaceuticals Ltd) (product)

SNOMED CT Concept\Pharmaceutical / biologic product\...

\UK product\Actual medicinal product\Xanthomax 300 tablets (Ashbourne Pharmaceuticals Ltd)
\UK product\Virtual medicinal product\Product containing precisely allopurinol 300 milligram/1 each conventional release oral tablet\Xanthomax 300 tablets (Ashbourne Pharmaceuticals Ltd)
\UK product\Virtual therapeutic moiety\Allopurinol\Product containing only allopurinol in oral dose form (medicinal product form)\Product containing precisely allopurinol 300 milligram/1 each conventional release oral tablet\Xanthomax 300 tablets (Ashbourne Pharmaceuticals Ltd)
\UK product\Virtual therapeutic moiety\Allopurinol\Product containing precisely allopurinol 300 milligram/1 each conventional release oral tablet\Xanthomax 300 tablets (Ashbourne Pharmaceuticals Ltd)
\UK product\Trade family\Xanthomax\Xanthomax 300 tablets (Ashbourne Pharmaceuticals Ltd)

\Medicinal product\Medicinal product categorized by disposition\Product containing enzyme inhibitor\Product containing xanthine oxidase inhibitor\Product containing allopurinol\Allopurinol\Product containing only allopurinol in oral dose form (medicinal product form)\Product containing precisely allopurinol 300 milligram/1 each conventional release oral tablet\Xanthomax 300 tablets (Ashbourne Pharmaceuticals Ltd)
\Medicinal product\Medicinal product categorized by disposition\Product containing enzyme inhibitor\Product containing xanthine oxidase inhibitor\Product containing allopurinol\Allopurinol\Product containing precisely allopurinol 300 milligram/1 each conventional release oral tablet\Xanthomax 300 tablets (Ashbourne Pharmaceuticals Ltd)
\Medicinal product\Medicinal product categorized by disposition\Product containing enzyme inhibitor\Product containing xanthine oxidase inhibitor\Product containing allopurinol\Product containing allopurinol in oral dose form (medicinal product form)\Product containing only allopurinol in oral dose form (medicinal product form)\Product containing precisely allopurinol 300 milligram/1 each conventional release oral tablet\Xanthomax 300 tablets (Ashbourne Pharmaceuticals Ltd)
\Medicinal product\Medicinal product categorized by structure\Product containing allopurinol\Allopurinol\Product containing only allopurinol in oral dose form (medicinal product form)\Product containing precisely allopurinol 300 milligram/1 each conventional release oral tablet\Xanthomax 300 tablets (Ashbourne Pharmaceuticals Ltd)
\Medicinal product\Medicinal product categorized by structure\Product containing allopurinol\Allopurinol\Product containing precisely allopurinol 300 milligram/1 each conventional release oral tablet\Xanthomax 300 tablets (Ashbourne Pharmaceuticals Ltd)
\Medicinal product\Medicinal product categorized by structure\Product containing allopurinol\Product containing allopurinol in oral dose form (medicinal product form)\Product containing only allopurinol in oral dose form (medicinal product form)\Product containing precisely allopurinol 300 milligram/1 each conventional release oral tablet\Xanthomax 300 tablets (Ashbourne Pharmaceuticals Ltd)
\Medicinal product\Product manufactured as oral dose form\Product containing allopurinol in oral dose form (medicinal product form)\Product containing only allopurinol in oral dose form (medicinal product form)\Product containing precisely allopurinol 300 milligram/1 each conventional release oral tablet\Xanthomax 300 tablets (Ashbourne Pharmaceuticals Ltd)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module

16135701000001110 Xanthomax 300 tablets (Ashbourne Pharmaceuticals Ltd) (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

16135801000001118 Xanthomax 300 tablets (Ashbourne Pharmaceuticals Ltd) en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Xanthomax 300 tablets (Ashbourne Pharmaceuticals Ltd)	Has excipient	Excipient not declared	true	Inferred relationship	Existential restriction modifier
Xanthomax 300 tablets (Ashbourne Pharmaceuticals Ltd)	Has NHS dm+d (dictionary of medicines and devices) controlled drug category	Controlled drug category No Controlled Drug Status	true	Inferred relationship	Existential restriction modifier
Xanthomax 300 tablets (Ashbourne Pharmaceuticals Ltd)	Is a	Product containing precisely allopurinol 300 milligram/1 each conventional release oral tablet	true	Inferred relationship	Existential restriction modifier
Xanthomax 300 tablets (Ashbourne Pharmaceuticals Ltd)	Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator	NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available	true	Inferred relationship	Existential restriction modifier
Xanthomax 300 tablets (Ashbourne Pharmaceuticals Ltd)	Has excipient	Lactose	false	Inferred relationship	Existential restriction modifier
Xanthomax 300 tablets (Ashbourne Pharmaceuticals Ltd)	Has active ingredient	Allopurinol	false	Inferred relationship	Existential restriction modifier
Xanthomax 300 tablets (Ashbourne Pharmaceuticals Ltd)	VMP prescribing status (attribute)	VMP valid as a prescribable product	true	Inferred relationship	Existential restriction modifier
Xanthomax 300 tablets (Ashbourne Pharmaceuticals Ltd)	VMP non-availability indicator	Available	true	Inferred relationship	Existential restriction modifier
Xanthomax 300 tablets (Ashbourne Pharmaceuticals Ltd)	Has manufactured dose form	Conventional release oral tablet	true	Inferred relationship	Existential restriction modifier
Xanthomax 300 tablets (Ashbourne Pharmaceuticals Ltd)	Is a	Xanthomax	true	Inferred relationship	Existential restriction modifier
Xanthomax 300 tablets (Ashbourne Pharmaceuticals Ltd)	Has specific active ingredient	Allopurinol	true	Inferred relationship	Existential restriction modifier
Xanthomax 300 tablets (Ashbourne Pharmaceuticals Ltd)	Has dispensed dose form	Tablet	true	Inferred relationship	Existential restriction modifier
Xanthomax 300 tablets (Ashbourne Pharmaceuticals Ltd)	Is a	Actual medicinal product	true	Inferred relationship	Existential restriction modifier

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Xanthomax 300 tablets (Ashbourne Pharmaceuticals Ltd) 28 tablet	Is pack of	False	Xanthomax 300 tablets (Ashbourne Pharmaceuticals Ltd)	Inferred relationship	Existential restriction modifier
Xanthomax 300 tablets (Ashbourne Pharmaceuticals Ltd) 28 tablet	Has AMP	True	Xanthomax 300 tablets (Ashbourne Pharmaceuticals Ltd)	Inferred relationship	Existential restriction modifier

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
16135701000001110	Xanthomax 300 tablets (Ashbourne Pharmaceuticals Ltd) (product)	en	Fully specified name	Active	Only initial character case insensitive	SNOMED CT United Kingdom drug extension module
16135801000001118	Xanthomax 300 tablets (Ashbourne Pharmaceuticals Ltd)	en	Synonym	Active	Only initial character case insensitive	SNOMED CT United Kingdom drug extension module